Insider Transactions in Q4 2020 at Glycomimetics Inc (GLYC)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 28
2020
|
Rachel K. King |
SELL
Open market or private sale
|
Direct |
84,176
-19.12%
|
$252,528
$3.91 P/Share
|
|
Dec 28
2020
|
Rachel K. King |
BUY
Exercise of conversion of derivative security
|
Direct |
130,821
+22.91%
|
$130,821
$1.12 P/Share
|
|
Dec 16
2020
|
Brian M. Hahn SVP Finance, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,260
+50.0%
|
$5,260
$1.12 P/Share
|
|
Nov 04
2020
|
Bvf Partners L P > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,266,737
+11.98%
|
$2,533,474
$2.6 P/Share
|
|
Oct 30
2020
|
Bvf Partners L P > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
932,612
+7.81%
|
$1,865,224
$2.75 P/Share
|